Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.
about
Tendinopathy in diabetes mellitus patients-Epidemiology, pathogenesis, and management.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.Metformin and its clinical use: new insights for an old drug in clinical practice.The role of psychobiological and neuroendocrine mechanisms in appetite regulation and obesity.Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.Roles of leptin in bone metabolism and bone diseases.Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials.Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study.Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK-ERK signalling pathway in vivo and in vitro.Adiponectin as an independent predictor of left ventricular hypertrophy in nondiabetic patients with hypertension.Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease.Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance.
P2860
Q30238916-6776AC48-1CF2-41C9-A821-6F4ACF59E282Q33846858-4A25C4FF-A2D9-44CB-951F-142F6B55265EQ35101262-21E61AB3-5717-4AFE-8423-FAD458BAABF9Q36423076-89FA9BA6-2D5A-44F4-86AB-ECF0FE96B803Q36547159-53A84049-FF71-422D-AAFC-47A6EAFBEFE7Q38188874-C6F15BAA-A60E-45E8-A266-0BFB9188591BQ38380562-CF297D42-E866-44DE-9AC5-F011CE9409F5Q39038137-DA8AA6D9-3298-472B-9A54-4DB746DB4381Q39399592-462BBD61-F3B8-455B-98EB-FCD1548724F4Q48160398-B467D7A1-D10D-404A-8C04-B536F36CA555Q51326375-EB4CB7CA-8259-4FEB-B98B-344D9E10413EQ51373008-553C7615-99DA-4C50-A0E2-6BCF8C28D850Q51745912-2B061329-8927-4DF3-9332-FEB3D60E2372
P2860
Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of various treatments o ...... with type 2 diabetes mellitus.
@en
Effect of various treatments o ...... with type 2 diabetes mellitus.
@nl
type
label
Effect of various treatments o ...... with type 2 diabetes mellitus.
@en
Effect of various treatments o ...... with type 2 diabetes mellitus.
@nl
prefLabel
Effect of various treatments o ...... with type 2 diabetes mellitus.
@en
Effect of various treatments o ...... with type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
Effect of various treatments o ...... with type 2 diabetes mellitus.
@en
P2093
Anna Gotzamani-Psarrakou
Dimitrios Karamitsos
John G Yovos
Niki Katsiki
P2860
P304
P356
10.1517/14728222.2011.553609
P407
P577
2011-01-25T00:00:00Z